Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Large scale serum proteomics identifies proteins associated with performance decline and clinical milestones in Duchenne muscular dystrophy

N.A. Ikelaar, A.M. Barnard, S.W.M. Eng, S. Hosseini Vajargah, K.C.H. Ha, H.E. Kan, K. Vandenborne, E.H. Niks, G.A. Walter, View ORCID ProfileP. Spitali
doi: https://doi.org/10.1101/2024.08.05.24311516
N.A. Ikelaar
1Department of Neurology, Leiden University Medical Center, Leiden, Zuid-Holland, the Netherlands
2Duchenne Center Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.M. Barnard
3Department of Physical Therapy, University of Florida, Gainesville, FL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S.W.M. Eng
4BioSymetrics, Inc., Huntington, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Hosseini Vajargah
4BioSymetrics, Inc., Huntington, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K.C.H. Ha
4BioSymetrics, Inc., Huntington, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H.E. Kan
2Duchenne Center Netherlands
5C.J. Gorter MRI Center, Department of Radiology, Leiden University Medical Center, Leiden, Zuid-Holland, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Vandenborne
3Department of Physical Therapy, University of Florida, Gainesville, FL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E.H. Niks
1Department of Neurology, Leiden University Medical Center, Leiden, Zuid-Holland, the Netherlands
2Duchenne Center Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G.A. Walter
6Department of Physiology and Aging, University of Florida, Gainesville, FL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Spitali
7Human Genetics Department, Leiden University Medical Center, Leiden, Zuid-Holland, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for P. Spitali
  • For correspondence: p.spitali{at}lumc.nl
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Abstract

Serum biomarkers are promising minimally invasive outcome measures in clinical studies in Duchenne muscular dystrophy (DMD). However, biomarkers strongly associated with clinical progression and predicting performance decline are lacking. In this study we aimed to identify serum biomarkers associated with clinical performance and able to predict clinical milestones in DMD. Towards this aim we present a retrospective multi-center cohort study including serum samples and clinical data collected in research participants with DMD as part of a natural history study at the University of Florida (UF) and real-world observations at Leiden University Medical Center (LUMC) between 2009-2022. The 7K SomaScan® assay was used to analyse protein levels in in individual serum samples. Serum biomarkers predicted age at loss of ambulation (LoA), age at loss of overhead reach (OHR) and age at loss of hand to mouth function (HTM). Secondary outcomes were the association of biomarkers with age, corticosteroid (CS) usage, and clinical performance based on the North Star Ambulatory Assessment (NSAA), 10 meter run velocity (10mrv), 6 minute walk (6MWT) and Performance of the Upper Limb (PUL2.0). A total of 716 serum samples were collected in 79 participants at UF and 74 at LUMC (mean[SD] age; 10.9[3.2] vs 8.4[3.4]). 244 serum proteins showed an association with CS usage in both cohorts independent of CS type and regimen, including MMP3 and IGLL1. 318 probes (corresponding to 294 proteins) showed significant associations with NSAA, 10mrv, 6MWT and/or PUL2.0 across both cohorts. The expression of 38 probes corresponding to 36 proteins such as RGMA, EHMT2, ART3, ANTXR2 and DLK1 was associated with risk of both lower and upper limb clinical milestones in both the LUMC and UF cohort. In conclusion, multiple biomarkers were associated with CS use, motor function and upper lower and upper limb disease milestones in DMD. These biomarkers were validated across two independent cohorts, increasing their likelihood of translation for use within the broader DMD population.

Competing Interest Statement

SWME, SVH, and KCHH are employees of BioSymetrics, which has a commercial interest in the results. The remaining authors have no competing interests.

Funding Statement

This study was funded by Parent Project Muscular Dystrophy through the Protein Mapping Project. Research reported in this publication was also partially supported by Spieren voor Spieren (grant number Svs15) and National Institute Of Neurological Disorders And Stroke of the National Institutes of Health under Award Number # R61NS119639 (Co-I: Spitali), R01 AR056973 (PI: K Vandenborne), and R01 AR065943 (PI: GA Walter). Research reported in this publication was also supported by the CTSI Biorepository at the University of Florida Clinical and Translational Science Institute, which is supported in part by the NIH National Center for Advancing Translational Sciences under award number UL1 TR001427. The authors thank the staff and participants for their contributions.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Written consent was obtained from all participants or their caregivers as described in protocol B22.013 at LUMC and protocols IRB201500981 and IRB201700056 at UF, which were approved by the respective regulatory boards at both sites.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted August 07, 2024.
Download PDF
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Large scale serum proteomics identifies proteins associated with performance decline and clinical milestones in Duchenne muscular dystrophy
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Large scale serum proteomics identifies proteins associated with performance decline and clinical milestones in Duchenne muscular dystrophy
N.A. Ikelaar, A.M. Barnard, S.W.M. Eng, S. Hosseini Vajargah, K.C.H. Ha, H.E. Kan, K. Vandenborne, E.H. Niks, G.A. Walter, P. Spitali
medRxiv 2024.08.05.24311516; doi: https://doi.org/10.1101/2024.08.05.24311516
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Large scale serum proteomics identifies proteins associated with performance decline and clinical milestones in Duchenne muscular dystrophy
N.A. Ikelaar, A.M. Barnard, S.W.M. Eng, S. Hosseini Vajargah, K.C.H. Ha, H.E. Kan, K. Vandenborne, E.H. Niks, G.A. Walter, P. Spitali
medRxiv 2024.08.05.24311516; doi: https://doi.org/10.1101/2024.08.05.24311516

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)